Slide 1: Investor Presentation
Investor Presentation June 2024 ASX:AGH
Slide 2: Althea Group Platform
ALTHEA GROUP PLATFORM We operate three separate and distinct strategic business units: Peak Processing Solutions (Peak), Althea & MyAccess Clinics. RECREATIONAL CANNABIS PHARMACEUTICAL CANNABIS Peak partners with consumer-packaged Althea is a global leader in the sales and MyAccess Clinics is one of
Slide 3: USA Cannabis Beverages Opportunity
USA Cannabis Beverages Opportunity
Slide 4: Positive Tailwinds
POSITIVE TAILWINDS Positive market response to Regulatory de-risking and Improved regulatory conditions DEA's decision, indicating potential productivity gains for and tax reforms could enhance potential growth opportunities Peak USA, amidst evolving Peak USA's competitive position for cannabis comp
Slide 5: USA Cannabis Beverage Opportunity
USA CANNABIS BEVERAGE OPPORTUNITY Peak USA will replicate the successful business model of Peak Canada, using our proprietary emulsion Envision™ to produce hemp-derived cannabis-infused beverages Canadian Cannabis Infused Beverage Peak Processing Solutions leads the Market Canadian market in contrac
Slide 6: USA Cannabis Beverage Opportunity
USA CANNABIS BEVERAGE OPPORTUNITY Peak USA will replicate the successful business model of Peak Canada, using our proprietary emulsion Envision™ to produce hemp-derived cannabis-infused beverages US Cannabis Infused Beverage Market Florida Entry – CY24 (USD$) With a population of 22 million and mini
Slide 7: Existing US Stocked Product / Peak & Flora – Melo Seltzer
Existing US Stocked Product (sold in liqour stores) Peak & Flora – Melo Seltzer US Focused Products in Development
Slide 8: AGH Consolidated Group Highlights FY24 (Q1-Q3)
AGH Consolidated Group Highlights FY24 (Q1-Q3)
Slide 9: Financial Highlights
FINANCIAL HIGHLIGHTS FY24 to date has seen a significant focus on cost reduction & increasing revenues to deliver positive cashflows Customer Receipts Recreational Cannabis $27m Up 13% over PCP driven by continuing $13m Down 2% on pcp due to planned facility growth in the cannabis upgrade in July 20
Slide 10: Restructure Yielding Improved Results
RESTRUCTURE Restructure & cost reduction program implemented • AGH has completed the restructuring phase of its cost reduction program, YIELDING IMPROVED identified as part of the Company’s recently announced organisational review • The restructure is expected to deliver approximately $2.5m annualis
Slide 11: Recreational Cannabis Highlights FY24 (Q1-Q3)
Recreational Cannabis Highlights FY24 (Q1-Q3)
Slide 12: Peak Highlights
PEAK HIGHLIGHTS FY24 has seen a significant focus on cost reduction & increasing revenues to deliver positive cashflows Strong Sales & Springboard Cannabis-infused Beverages Market Consolidation • $13m in receipts from customers • The Canadian adult-use cannabis • Competition in the Canadian market
Slide 13: Our Customers
OUR CUSTOMERS Managing some of Canada’s top performing cannabis brands. Collective Project is a renowned Toyo Smoke is an award-winning, BC BUD CO. is a house of brands brand, developed by Collective Arts design-focused brand that based out of British Columbia Brewing, specialising in crafting seaml
Slide 14: Pharmaceutical Cannabis Highlights FY24 (Q1-Q3)
Pharmaceutical Cannabis Highlights FY24 (Q1-Q3)
Slide 15: Althea Highlights
ALTHEA HIGHLIGHTS Strategic commercial initiatives have Althea well placed for profitability and growth Strong Sales Growth & Increasing Strong Margins Althea’s Competitive Advantage Patient Base • $14m receipts from customers • Althea has sustained competitive • Althea recently became the worlds be
Slide 16: Softgel Capsules
SOFTGEL • Althea softgel capsules are available in CBD-dominant, balanced and CAPSULES THC-dominant formulations • Attractively priced for patients with strong margins, Althea believes softgel capsules are the next generation of cannabis extracts, superseding bottled oils ALTHEA PRODUCT PACK SIZE TG
Slide 17: MyAccess Clinics Highlights
MYACCESS CLINICS HIGHLIGHTS Delivering predictable and recurring sales of Althea products Increasing Patient Numbers In Germany’s Legalisation Of Germany Clinic Launching UK & Ireland Cannabis 2HCY24 • MyAccess Clinics has consulted with • The Federal Council of Germany has • Removing cannabis as a
Slide 18: Corporate Overview
CORPORATE OVERVIEW % total of Key Market Statistics Althea Group Holdings (ASX:AGH) Name Numbers held shares issued ASX code AGH Joshua Michael Fegan 57,588,651 14.20 Share price (5 June 2024) $0.027 HSBC Custody Nominees (Australia) 27,914,525 6.89 Limited Market capitalisation $10.9m Adman Lanes P
Slide 19: Board of Directors
BOARD OF DIRECTORS A highly credentialed & experienced Board, with deep experience in Pharmaceuticals, biotechnology & FMCG Andrew Newbold Joshua Fegan Penelope Dobson Alan Boyd Chairman & Chief Executive Officer & Independent Non-Executive Independent Non-Executive Independent Non-Executive Founder
Slide 20: Disclaimer
DISCLAIMER Althea Group Holdings Limited ACN 626 966 943 (Company) has prepared this presentation (Presentation) dated 5 June 2024 to provide current and prospective investors in the Company with an update in relation to the Company, its subsidiaries and their activities. The information in this Pre
Slide 21: Contact
Contact: Joshua Fegan - CEO Jfegan@altheagroupholdings.com.au